MYD88 Mutations and Sensitivity to Ibrutinib Therapy
- PMID: 29482770
- DOI: 10.1016/j.jmoldx.2017.11.006
MYD88 Mutations and Sensitivity to Ibrutinib Therapy
Abstract
This Correspondence relates to the article by Bobee et al (Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study. J Mol Diagn 2017,19:892-904).
Copyright © 2018 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Authors' Reply.J Mol Diagn. 2018 Mar;20(2):266. doi: 10.1016/j.jmoldx.2017.12.001. J Mol Diagn. 2018. PMID: 29482771
Comment on
-
Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.J Mol Diagn. 2017 Nov;19(6):892-904. doi: 10.1016/j.jmoldx.2017.07.007. Epub 2017 Oct 17. J Mol Diagn. 2017. PMID: 29054399
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources